Sharekhan

Zydus Wellness Ltd

Wed 21/05/2025,15:59:56 | NSE : ZYDUSWELL

₹ 1969.8048.90 (2.55%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1937.50

Previous Close

₹ 1920.90

Volume

225578

Mkt Cap ( Rs. Cr)

₹12534.26

High

₹ 2018.00

Low

₹ 1919.00

52 Week High

₹ 2484.00

52 Week Low

₹ 1493.20

Book Value Per Share

₹ 863.45

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Zydus Wellness Ltd

Your Vote -

Buy

22.50%

Hold

43.33%

Sell

34.17%

22.50%

120 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

1969.80

11

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

11

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Zydus Wellness Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Zydus Wellness Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    19 May 2025, 8:53PM Audio recording
  • Zydus Wellness Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates

    19 May 2025, 8:53PM Zydus Wellness Limited has informed the Exchange about Link of Recording
  • Zydus Wellness Ltd. - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    19 May 2025, 6:26PM ZYDUS WELLNESS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agen
  • Zydus Wellness Ltd. - Alteration Of Capital and Fund Raising-XBRL

    19 May 2025, 5:26PM ZYDUS WELLNESS LIMITED has informed the Exchange regarding Alteration of capital
  • Zydus Wellness Ltd. - Outcome of Board Meeting-XBRL

    19 May 2025, 5:00PM ZYDUS WELLNESS LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 19-May-2025 for Dividend
  • Zydus Wellness Ltd. - Appointment

    19 May 2025, 1:12PM Zydus Wellness Limited has informed the Exchange regarding Appointment of Mr Mukesh M Shah as Other of the company w.e.f. April 01, 2025.
  • Zydus Wellness Ltd. - Appointment

    19 May 2025, 1:10PM Zydus Wellness Limited has informed the Exchange regarding Appointment of Mr Hitesh Buch as Other of the company w.e.f. April 01, 2025.
  • Zydus Wellness Ltd. - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

    19 May 2025, 1:07PM Re-appointment of Statutory Auditors
  • Zydus Wellness Ltd. - Appointment Of Secretarial Auditors

    19 May 2025, 1:05PM Appointment of Secretarial Auditors
  • Zydus Wellness Ltd. - Record Date

    19 May 2025, 1:03PM Zydus Wellness Limited has informed the Exchange that Record date for the purpose of Dividend is 11-Jul-2025.
  • Zydus Wellness Ltd. - Friday, July 11, 2025

    19 May 2025, 1:03PM Record date
  • Zydus Wellness Ltd. - Press Release

    19 May 2025, 1:00PM Zydus Wellness Limited has informed the Exchange regarding a press release dated May 19, 2025, titled ""Press Release"".
  • Zydus Wellness Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    19 May 2025, 1:00PM Press release
  • Zydus Wellness Ltd. - Announcement under Regulation 30 (LODR)-Investor Presentation

    19 May 2025, 12:59PM Presentation
  • Zydus Wellness Ltd. - Investor Presentation

    19 May 2025, 12:54PM Zydus Wellness Limited has informed the Exchange about Investor Presentation
  • Zydus Wellness Ltd. - Stock split

    19 May 2025, 12:49PM Zydus Wellness Limited has informed the Exchange that the Board of Directors at its meeting held on May 19, 2025, has considered and approved subdivis
  • Zydus Wellness Ltd. - Corporate Action-Board approves Dividend

    19 May 2025, 12:48PM Dividend of Rs. 6 per share
  • Zydus Wellness Ltd. - Audited Financial Results For The Year Ended On March 31, 2025

    19 May 2025, 12:47PM Audited Financial Results for the year ended on March 31, 2025
  • Zydus Wellness Ltd. - Dividend

    19 May 2025, 12:44PM Zydus Wellness Limited has informed the Exchange that Board of Directors at its meeting held on May 19, 2025, recommended Final Dividend of Rs. 6.00 p
  • Zydus Wellness Ltd. - Board Meeting Outcome for Audited Financial Results For The Financial Year Ended On March 31, 2025

    19 May 2025, 12:43PM Audited Financial Results for the financial year ended on March 31, 2025
  • Zydus Wellness Q4 net profit down 36.49% at Rs 4.70 cr

    19 May 2025, 12:42PM The company reported standalone net profit of Rs 4.70 crore for the quarter ended March 31, 2025 as compared to Rs 7.40 crore in the same period last
  • Zydus Wellness Ltd. - Outcome of Board Meeting

    19 May 2025, 12:42PM Zydus Wellness Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
  • Zydus Wellness Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates

    13 May 2025, 11:13AM Zydus Wellness Limited has informed the Exchange about Schedule of meet
  • Zydus Wellness Ltd. - Board Meeting Intimation

    9 May 2025, 5:25PM ZYDUS WELLNESS LIMITED has informed the Exchange about Board Meeting to be held on 19-May-2025 to consider and approve the Yearly Audited Financial re
  • Zydus Wellness Ltd. - Board Meeting Intimation for Approval Of Financial Results, Recommendation Of Dividend And Proposal For

    9 May 2025, 5:12PM Zydus Wellness Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and
  • Zydus Wellness Ltd. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    12 Apr 2025, 7:00PM As of March 2025, 69.64% is owned by Indian Promoters and 30.37% by Public. <p align=justify> Institutional holds 23.05% (Insurance Companies 0.80%) a
  • Zydus Wellness Ltd. - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Apr 2025, 10:04AM Zydus Wellness Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Zydus Wellness Ltd. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Apr 2025, 10:06AM Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on March 31, 2025
  • Zydus Wellness Ltd. - Receipt Of Cautionary Email From NSE And BSE

    29 Mar 2025, 2:58PM Receipt of cautionary email from NSE and BSE
  • Zydus Wellness Ltd. - Action(s) taken or orders passed

    29 Mar 2025, 2:58PM Zydus Wellness Limited has informed the Exchange about Action(s) taken or orders passed
  • Zydus Wellness Ltd. - Updates

    28 Mar 2025, 3:11PM Zydus Wellness Limited has informed the Exchange regarding 'Disclosure under Insider Trading Regulations'.
  • Zydus Wellness Ltd. - Updates

    26 Mar 2025, 4:40PM Zydus Wellness Limited has informed the Exchange regarding 'Disclosure under Insider Trading Regulations'.
  • Zydus Wellness Ltd. - Trading Window-XBRL

    25 Mar 2025, 4:14PM ZYDUS WELLNESS LIMITED has informed the Exchange about Closure of Trading Window
  • Zydus Wellness Ltd. - Trading Window

    25 Mar 2025, 4:13PM Zydus Wellness Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2
  • Zydus Wellness Ltd. - Updates

    24 Mar 2025, 9:47AM Zydus Wellness Limited has informed the Exchange regarding 'Disclosure under Insider Trading Regulations'.
  • Zydus Wellness Ltd. - Updates

    20 Mar 2025, 10:32PM Zydus Wellness Limited has informed the Exchange regarding 'Disclosure under Insider Trading Regulations'.
  • Zydus Wellness Ltd. - Updates

    18 Mar 2025, 2:57PM Zydus Wellness Limited has informed the Exchange regarding 'Disclosure under Insider Trading Regulations'.
  • Zydus Wellness Ltd. - Updates

    17 Mar 2025, 1:04PM Zydus Wellness Limited has informed the Exchange regarding 'Disclosure under Insider Trading Regulations'.
  • Zydus Wellness Ltd. - Updates

    13 Mar 2025, 11:45AM Zydus Wellness Limited has informed the Exchange regarding 'Disclosure under Insider Trading Regulations'.
  • Zydus Wellness Ltd. - Updates

    7 Mar 2025, 10:53PM Zydus Wellness Limited has informed the Exchange regarding 'Disclosure under Insider Trading Regulations'.
  • Zydus Wellness Ltd. - Action(s) initiated or orders passed

    27 Feb 2025, 1:12PM Zydus Wellness Limited has informed the Exchange about Action(s) initiated or orders passed
  • Zydus Wellness Ltd. - Disclosure Of Receipt Of Show Cause Notice From DGGI

    27 Feb 2025, 1:14PM Disclosure of receipt of Show Cause Notice from DGGI
  • Zydus Wellness Ltd. - Updates

    26 Feb 2025, 6:11PM Zydus Wellness Limited has informed the Exchange regarding ESG Score.
  • Zydus Wellness Ltd. - Intimation Of ESG Score

    26 Feb 2025, 6:09PM Intimation of ESG Score
  • Zydus Wellness Ltd. - Action(s) taken or orders passed

    26 Feb 2025, 5:19PM Zydus Wellness Limited has informed the Exchange about Action(s) taken or orders passed
  • Zydus Wellness Ltd. - Receipt Of Assessment Order Under CGST Act, 2017

    26 Feb 2025, 5:18PM Receipt of Assessment Order under CGST Act, 2017
  • Stock update: Zydus Wellness Q3FY25 (Consolidated) result update

    14 Feb 2025 , 10:59AM Stock update: Zydus Wellness Q3FY25 (Consolidated) result update – Mixed bag Q3
  • Zydus Wellness

    30 Dec 2024 , 12:13PM As per a regulatory filing, Zydus Wellness Products Ltd (ZWPL), a wholly-owned subsidiary of ZWL, has received a GST demand of Rs. 56.33 crore, along with applicable interest and penalty from the tax authority. The intimation alleges that the GST was payable in relation to the acquisition of intellectual property rights from Heinz Italia S.P.A. by Heinz India Pvt Ltd, now merged with ZWPL.
  • Zydus Wellness

    31 Oct 2024 , 9:37AM The company has announced that it will acquire 100% stake in Naturell (India) Private Limited (NIPL) including its wholly owned subsidiary for a consideration of Rs. 390 crore. NIPL is a leading healthy snacking company engaged in the business of manufacturing, research and development and marketing of Nutrition bars, Protein cookies, Protein Chips and health food products. NIPL’s business portfolio includes brands – Ritebite Max Protein (Protein fueled healthy snacks) and Ritebite (fiber-enriched snacks).
  • Stock update: Zydus Wellness

    28 Aug 2024 , 11:33AM Stock update: Zydus Wellness – Focused strategies to drive double-digit growth
  • Stock update: Zydus Wellness Q2FY2024 (Consolidated) result update

    7 Nov 2023 , 11:31AM Stock update: Zydus Wellness Q2FY2024 (Consolidated) result update – Soft Q2; long-term prospects intact
  • Zydus Wellness

    14 Aug 2023 , 10:14AM Delhi high court Passed injunction order restraining the company from using trade mark “Sugarlite” – negative read through for the stock
  • Zydus Wellness

    4 Jul 2023 , 10:44AM The Delhi High Court has restrained Cipla Health from using trademark Gluco-C or Gluco-D. The court’s order brings relief to Zydus Wellness, which manufactures and sells energy drink Glucon-C and Glucon-D. Zydus Wellness had alleged that Cipla Health's Gluco-C and Gluco-D were similar to its registered trademarks. Positive for Zydus Wellness
  • Zydus Wellness

    6 Mar 2023 , 1:13PM Zydus Wellness: Betting on strong summer season; valuations attractive after recent correction
  • Zydus Wellness Q3FY2023 (Consolidated) result update

    2 Feb 2023 , 2:42PM Zydus Wellness Q3FY2023 (Consolidated) result update – Mixed Q3; margins improved sequentially
  • Zydus Wellness Q2FY2023 (Consolidated) result update

    10 Nov 2022 , 1:14PM Zydus Wellness Q2FY2023 (Consolidated) result update – Sharp decline in margins was drag on bottomline; market share gains continued
  • Zydus Wellness Q1FY2023 (Consolidated) result update

    29 Jul 2022 , 1:54PM Zydus Wellness Q1FY2023 (Consolidated) result update – Q1 beat on estimates; market share gains continued
  • Zydus Wellness

    30 Jun 2022 , 2:05PM Zydus Wellness: In one of the management meet, Zydus wellness stated that the company will focus on improving the brand awareness and add 4-5 new products/variants to support double digit growth. Aims to widen direct distribution coverage to 3.5-4.0mn outlets from current 2.25mn outlets. Targets to have 8-10% growth of revenues from international business in next 4-5 years from 4% in FY2022
  • Zydus Wellness

    20 Jun 2022 , 11:59AM The Company manufacturing unit situated at Sitarganj (Udhamsingh Nagar), Uttarkhand ceased operation with effect from 18th June, 2022. As a part of manufacturing and supply chain network optimisation and make manufacturing operations leaner and agile to the consumer needs, the Company (& its subsidiaries) has conducted a strategic review of its manufacturing plants. The company does not anticipate any material effect due to decision since the products manufactured at said facility will be manufactured at other locations of the company.
  • Zydus receives final approval from USFDA for Nitroglycerin Sublingual Tablets

    10 Mar 2022 , 11:50AM Nitroglycerin Sublingual Tablets are use to relieve chest pain in people who have a certain heart condition
  • Zydus Wellness

    7 Mar 2022 , 12:04PM Zydus Lifesciences (Earlier known as Cadila): Gets Drug Controller General of India approval for its ANDA – Oxemia (Desidustat), which is a first-of-its-kind oral treatment in India for anemia associated with Chronic Kidney Disease. The treatment offers ease of convenience for patients and also reduce the disease burden by providing an affordable cost option. In India around 115.1 mn are reported to be suffering from this disease and thus points at a healthy addressable market size. Positive
  • Zydus Lifesciences gets Indian regulator nod for Desidustat

    7 Mar 2022 , 11:31AM Zydus to launch Oxemia a breakthrough treatment for Anemia in patients suffering from Chronic Kidney Disease
  • Zydus Wellness Q3FY2022 (consolidated) result update

    2 Feb 2022 , 2:06PM Zydus Wellness Q3FY2022 (consolidated) result update – Below par performance
  • Zydus Wellness: Good performance

    2 Aug 2021 , 11:49AM Zydus Wellness: Good performance in a tough environment
  • Zydus Wellness - revenues came in line

    30 Jul 2021 , 3:04PM Zydus Wellness - revenues came in line; margins bit estimates; lower interest cost fuelled the strong bottomline growth
  • Zydus Wellness: Q4FY2021 result update

    11 May 2021 , 10:54AM Zydus Wellness: Q4FY2021 result update - Strong Q4; long term levers intact
  • Zydus Wellness register strong performance in Q4

    10 May 2021 , 2:59PM Zydus Wellness: Strong operating performance
  • Zydus Wellness

    5 Apr 2021 , 10:26AM Zydus Wellness: The Company Introduced ViroShield mouth spray as OTC product..It will be available in market in a week time.This spray gives protection against Covid and other Viruses for few hours and one can take it multiple times a day..This mouth spray can be a tool for who has to go to work and has to meet people ..Seems very useful product specially when corona second wave is in full flow in India.
  • Zydus Wellness: Strong Q3

    2 Feb 2021 , 10:14AM Zydus Wellness: Strong Q3; Repayment of NCDs boosted PAT growth
  • Zydus Wellness Q3FY21 Result First cut

    1 Feb 2021 , 3:44PM Zydus Wellness Q3FY21 Result First cut - Strong growth, Revenue grew by 15%
  • Zydus Wellness: Soft Q2

    3 Nov 2020 , 11:02AM Zydus Wellness: Soft Q2; de-leveraging on track
  • Zydus Wellness Q2FY2021 first cut

    2 Nov 2020 , 1:48PM Zydus Wellness Q2FY2021 first cut – Revenue in line, unfavourable mix affected margins
  • Zydus Wellness

    8 Oct 2020 , 11:13AM The board has given approval to repurchase debentures of Rs. 1500 crore it had issued during the acquisition of Heinz in January 11, 2019
  • Zydus Wellness - Stock update

    30 Sep 2020 , 11:31AM Zydus Wellness : Stock Update - Equity issuance to reduce debt; three pillars strategy to drive growth
  • Zydus Wellness raises Rs. 650 crore through issuance of shares to QIBs

    29 Sep 2020 , 2:18PM Allotment of equity shares to QIPs.
  • Zydus Wellness

    29 Sep 2020 , 11:51AM Zydus Wellness: Key highlights of our interaction with the management
  • Zydus Wellness

    24 Sep 2020 , 9:50AM The board of has set Rs1775.85 per share as floor price for QIP issue of Rs750crore (3.3% premium to yesterday's closing price of Rs1718). With the QIP issue the company equity will be enhanced by 0.42crore shares. Earlier the company raised Rs350crore through preferential allotment to promoters. Overall there will be equity dilution of 10% over post issue share capital.
  • Zydus Wellness

    14 Sep 2020 , 9:33AM Zydus Wellness: The company focuses on three pronged strategy to drive growth in the near to medium term - Positive read
  • Zydus Wellness

    10 Sep 2020 , 9:56AM The company has slightly revised the floor price of preferential issue to be made to Zydus family trust at Rs1649 per share (from Rs1643.1 per share); 21,22000 equity shares will be issue at the revised floor price. Post allotment Zydus trust will held 45,93193 equity shares (7.7% on post issuance equity).
  • GMR Infrastructure, Zydus Wellness

    28 Aug 2020 , 10:12AM GMR Infrastructure: The company’s board approved raising of funds up to Rs. 5000 crores in one or more tranches, through issue of securities as an enabling resolution.
  • Oil and Natural Gas Corporation, Zydus Wellness

    25 Aug 2020 , 9:19AM Oil and Natural Gas Corporation (ONGC): The company board of directors will meet on September 01, 2020 to consider fund raising of up to Rs45,000 crore by way availing bank loans or issue of debt securities (including bonds, NCDs and notes) in domestic or overseas market (including draw downs under Euro Medium Term Note Program) up to Rs35000 crore and availing loans not exceeding Rs10,000 crore against bank term deposits.
  • Zydus Wellness

    3 Aug 2020 , 10:36AM Zydus Wellness: Stock Update - Decent show in tough times
  • Zydus Wellnes Ltd

    31 Jul 2020 , 2:10PM Zydus Wellness (ZWL) Q1FY2021 results: Better than expected performance
  • Zydus Wellness

    14 Jul 2020 , 9:50AM Zydus Wellness: All facilities are operating currently; the company expects recovery in the next two quarters
  • Zydus Wellness

    3 Jun 2020 , 11:27AM Zydus Wellness: Q4FY2020 - Good Q4, stable balance sheet; Upgraded to Buy
  • Zydus Wellness

    2 Jun 2020 , 2:33PM Zydus Wellness Q4FY2020 results - better than expectation
  • Zydus Wellness

    6 Feb 2020 , 12:31PM Zydus Wellness: Stock Update – Subdued performance
  • Zydus Wellness

    5 Feb 2020 , 1:38PM Zydus Wellness Q3FY2020 – results not comparable; OPM improves 357BPS sequentially
  • CARE Ratings revises and reaffirms the rating of Zydus Wellness

    3 Jan 2020 , 2:08PM Review of Credit rating of 15,000, 9.14% secured, listed, rated, NCDs of Zydus Wellness
  • Zydus Wellness

    14 Nov 2019 , 11:35AM Zydus Wellness: Stock Update - Seasonality affected Q2 performance
  • Zydus Wellness

    13 Nov 2019 , 2:09PM Zydus Wellness Q2FY2020 Consolidated results – Weak quarter
  • Zydus Wellness: Stock Update

    1 Aug 2019 , 12:21PM Zydus Wellness: Stock Update – Heinz portfolio shines
  • Zydus Wellness promoter pledged 6.3% stake with Kotak Mahindra Investment

    1 Mar 2019 , 10:55AM As per media reports, Zydus Wellness promoter pledged 6.3% stake with Kotak Mahindra Investment – sentimentally negative read through
  • Zydus Wellness gets CCI nod for acquisition of Heinz India

    12 Dec 2018 , 10:32AM Zydus Wellness' acquisition of Heinz India receives a nod from Competition Regulator
  • Zydus Wellness plans to raise funds

    7 Dec 2018 , 12:36PM Zydus Wellness plans to raise Rs. 2,574.99 crore through issue of shares on a preferential basis
  • Zydus Wellness to acquire Heinz India

    24 Oct 2018 , 12:57PM Zydus Wellness to acquire Heinz India, catapulting it amongst the leading consumer health businesses in India
  • Kraft Heinz agrees to sell Complan to Zydus Wellness

    24 Oct 2018 , 10:44AM Zydus Wellness: Kraft Heinz Co. has agreed to sell a portfolio of Indian assets (including complain) for Rs46 billion to Zydus Wellness – positive read through but acquisition is yet to be confirmed by the management
  • Zydus Wellness: Stock Update

    5 Sep 2018 , 11:34AM Zydus Wellness: Stock Update - Growth momentum to sustain
  • Zydus Wellness: Stock update - Q1FY2019 result

    6 Aug 2018 , 3:13PM Zydus Wellness: Stock update - Q1FY2019 result - Strong performance continued; Maintain Buy with upgraded PT of Rs1,700
  • Zydus Wellness reports strong performance

    25 May 2018 , 12:50PM Upgrade to Buy with a revised PT of Rs. 1,400.
  • Zydus Wellness grew by 22% in Q3FY18

    8 Feb 2018 , 3:59PM Strong performance from Zydus Wellness, so upgrade to Buy with a revised PT to Rs. 1,255
  • Zydus wellness Q2 revenues grow in double digit

    14 Nov 2017 , 12:02PM Zydus Wellness: Q2FY2018 result update – Growth prospects improving (maintained Hold; PT – Rs952)
  • Zydus Wellness Q2 revenues grew by 11.0%

    13 Nov 2017 , 3:10PM Zydus Wellness Q2FY2018 consolidated results – ahead of expectation; revenues and PAT grew in double digits
  • Zydus Wellness Q1FY2018 stock update

    11 Aug 2017 , 9:50AM Zydus reported marginal decline of 1.1% YoY in its revenue to Rs115.5 cr on account of inventory de-stocking

Key fundamentals

Evaluate the intrinsic value of Zydus Wellness Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 4163.6 4085.9 4034.28 4046.18 4069.04
Liabilities 4163.6 4085.9 4034.28 4046.18 4069.04
Equity 63.6 63.6 63.63 63.63 63.63
Gross Profit 36.6 33 38.31 -5.32 -49.72
Net Profit 30.6 33.7 66.42 12.7 -182.14
Cash From Operating Activities 45.7 26 36.67 -16.27 -51.95
NPM(%) 10.45 13.76 26.41 5.87 -160.01
Revenue 292.6 244.8 251.48 216.25 113.83
Expenses 256 211.8 213.17 221.57 163.55
ROE(%) 0.55 0.61 1.2 0.23 -3.31

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
6 60 0 1832.6
19 Jul 2024 5 50 0 1729.2
21 Jul 2023 5 50 0 1481.15
14 Jul 2022 5 50 0 1665.6
14 Jul 2021 5 50 0 2108.85
19 Mar 2020 5 50 0 1415.15
0 0 0 1471.1
17 Jul 2019 5 50 0 1328.65
18 Jul 2018 8 80 0 1254.4
09 Mar 2017 6.5 65 0 821.75
16 Mar 2016 6.5 65 0 700.3
16 Jul 2015 6 60 0 1000.35
03 Jul 2014 6 60 0 525.1
18 Jul 2012 5 50 0 364.55
22 Jun 2011 4 40 0 579.5
08 Jul 2010 3 30 0 397.5

Peers

Other companies within the same industry or sector that are comparable to Zydus Wellness Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sundrop Brands Ltd 800.35 -0.83 0.00 4794.48 -291.51 0.00
Anik Industries Ltd 112.11 0.07 0.00 5460.36 1.09 0.00
BCL Industries Ltd 39.42 0.95 12.55 53583.50 305.92 0.63
AVT Natural Products Ltd 66.03 1.82 22.46 29961.12 349.93 1.21

Company Info

Mr Chintal D Sakaria, has been appointed as Company Secretary and Compliance Officer wef from November 14, 2003. 2009 - Company name has been changed from Carnation Nutra-Analogue Foods Ltd to Zydus Wellness Ltd. 2010 -Zydus Wellness - Board recommends Dividend @ 30% i.e. Rs. 3/- per Equity Share on 39,072,089 Equity Shares of Rs. 10/- each of the Company for the year ended on March 31, 2010. 2011 - Zydus Wellness recommends Dividend Rs. 4/- (At the rate of 40%) per equity share on 39072089 equity shares of Rs. 10/- each for the financial year ended on March 31, 2011 2012 -Elkana Ezekiel joins Zydus Wellness as CEO - ydus Wellness recommends Dividend of dividend @ 50% i.e. Rs. 5/- per Equity Share on 3,90,72,089 Equity Shares of Rs. 10/- each of the Company for the year ended on March 31, 2012. 2013 - The Company has declared interim dividend @ 60% i.e. Rs. 6/- per Equity Share. -The Registered office of the company has been changed from Zydus Tower, Satellite Cross Roads, Sarkhej-Gandhinagar Highway, Ahmedabad - 380 015 to House No. 6 & 7, Sigma Commerce Zone, Nr. Iscon temple, Sarkhej - Gandhinagar Highway, Ahmedabad - 380 015. 2014 - The Board of Directors appointed Dr. Sharvil P. Patel as the Chairman of the Board. - The Company has recommended a dividend @ 60% i.e. Rs. 6/- per Equity Share. 2016 -Zydus bags approval for Amantadine Capsules -Zydus acquires Melgain from Issar Pharma 2017 - The company has received approval from the US Food and Drug Administration (USFDA) to market the drug in strengths of 25 mg, 50 mg and 100 mg. 2018 The company inform that the members holding shares as on the cut-off date, i.e. July 26, 2018, will be entitled to exercise their voting rights electronically or at the venue of the Annual General Meeting. will be entitled to exercise their voting rights electronically or at the venue of the Annual General Meeting. 2019 -This is to inform that Hon'ble National Company Law Tribunal, Bench at Ahmedabad has passed an order dated May 10, 2019 approving the Scheme of Amalgamation (Scheme) between two subsidiaries, Heinz India Private Limited (Heinz) with Zydus Nutritions Limited (ZNL). Upon amalgamation, Heinz has ceased to be in existence and also to be the subsidiary of the Company. 2022 -A moment of pride! ZWPL recognised among top manufacturing Facilities. 2024 -Zydus Wellness join hands with Shahid Kapoor for product launch. -Zydus Wellness enters into packaged foods segment.

Mr Chintal D Sakaria, has been appointed as Company Secretary and Compliance Officer wef from November 14, 2003. 2009 - Company name has been changed from Carnation Nutra-Analogue Foods Ltd to Zydus Wellness Ltd. 2010 -Zydus Wellness - Board recommends Dividend @ 30% i.e. Rs. 3/- per Equity Share on 39,072,089 Equity Shares of Rs. 10/- each of the Company for the year ended on March 31, 2010. 2011 - Zydus Wellness recommends Dividend Rs. 4/- (At the rate of 40%) per equity share on 39072089 equity shares of Rs. 10/- each for the financial year ended on March 31, 2011 2012 -Elkana Ezekiel joins Zydus Wellness as CEO - ydus Wellness recommends Dividend of dividend @ 50% i.e. Rs. 5/- per Equity Share on 3,90,72,089 Equity Shares of Rs. 10/- each of the Company for the year ended on March 31, 2012. 2013 - The Company has declared interim dividend @ 60% i.e. Rs. 6/- per Equity Share. -The Registered office of the company has been changed from Zydus Tower, Satellite Cross Roads, Sarkhej-Gandhinagar Highway, Ahmedabad - 380 015 to House No. 6 & 7, Sigma Commerce Zone, Nr. Iscon temple, Sarkhej - Gandhinagar Highway, Ahmedabad - 380 015. 2014 - The Board of Directors appointed Dr. Sharvil P. Patel as the Chairman of the Board. - The Company has recommended a dividend @ 60% i.e. Rs. 6/- per Equity Share. 2016 -Zydus bags approval for Amantadine Capsules -Zydus acquires Melgain from Issar Pharma 2017 - The company has received approval from the US Food and Drug Administration (USFDA) to market the drug in strengths of 25 mg, 50 mg and 100 mg. 2018 The company inform that the members holding shares as on the cut-off date, i.e. July 26, 2018, will be entitled to exercise their voting rights electronically or at the venue of the Annual General Meeting. will be entitled to exercise their voting rights electronically or at the venue of the Annual General Meeting. 2019 -This is to inform that Hon'ble National Company Law Tribunal, Bench at Ahmedabad has passed an order dated May 10, 2019 approving the Scheme of Amalgamation (Scheme) between two subsidiaries, Heinz India Private Limited (Heinz) with Zydus Nutritions Limited (ZNL). Upon amalgamation, Heinz has ceased to be in existence and also to be the subsidiary of the Company. 2022 -A moment of pride! ZWPL recognised among top manufacturing Facilities. 2024 -Zydus Wellness join hands with Shahid Kapoor for product launch. -Zydus Wellness enters into packaged foods segment.

Read More

Parent Organisation

Zydus Wellness Ltd.

Founded

01/11/1994

Managing Director

Dr.Sharvil P Patel

NSE Symbol

ZYDUSWELLEQ

FAQ

The current price of Zydus Wellness Ltd is ₹ 1969.80.

The 52-week high for Zydus Wellness Ltd is ₹ 2018.00 and the 52-week low is ₹ 1919.00.

The market capitalization of Zydus Wellness Ltd is currently ₹ 12534.26. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Zydus Wellness Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Zydus Wellness Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Zydus Wellness Ltd shares.

The CEO of Zydus Wellness Ltd is Dr.Sharvil P Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT